The Primary Prevention of Intimate Partner Violence
Launched by EMORY UNIVERSITY · Feb 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called GBE (Ghya Bharaari Ekatra) designed to prevent intimate partner violence (IPV) among newly married couples. The goal is to see how effective this program is in reducing IPV, improving mental health, and promoting reproductive autonomy, which means making personal decisions about family and health. The trial will also explore how the program works, when it might need adjustments, and what factors could help it succeed in the future.
To participate in this trial, couples must be at least 18 years old, married for less than a year, and living together in a slum area of Mumbai or Pune, India. They should also speak Marathi and/or Hindi fluently. Both partners need to meet the eligibility criteria and attend the sessions together. It’s important to note that couples where the woman has experienced physical or sexual violence will not be included in the study, as they will be directed to appropriate support services. The trial is currently not recruiting participants, but it aims to gather valuable insights into preventing violence in intimate relationships.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • couples wherein both members are age ≥18 years,
- • married ≤ 1 year, in their first marriage, married to only one individual, cohabiting in a slum in Mumbai or Pune India, and
- • fluent in Marathi and/or Hindi
- • Both members of the couple must meet eligibility criteria and be present at the session for the couple to participate.
- Exclusion Criteria:
- • As GBE was designed for primary IPV prevention, couples in which the female member screens positive for physical and/or sexual IPV (using the modified Conflict Tactics Scale (CTS-2)) at baseline will be excluded (and referred to support services)
- • those in the 3rd trimester of pregnancy (as women traditionally return to their natal home during this perinatal period).
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mumbai, Maharashtra, India
Pune, Maharashtra, India
Patients applied
Trial Officials
Ameeta Kalokhe, MD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported